Results from a survey conducted by GfK in 2014 indicated that patients with systemic lupus erythematosus (SLE) have difficulties describing their symptoms to their physicians, leading to a gap in physicians’ understanding of the full impact the illness has on these patients’ lives. The survey was conducted by GfK on…
Inducing ovarian suppression in female patients with childhood-onset systemic lupus erythematosus (SLE) is protective against ovarian failure from treatment with cyclophophamide. A clinical trial from Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine has established a safe dose of triptorelin that effectively achieves and maintains complete…
A study recently published in the journal Arthritis & Rheumatology revealed that proteinuria is an accurate clinical predictor of long-term renal outcome in patients with lupus nephritis. The study was conducted by an international research team and is entitled “Predictors of Long-Term Renal Outcome…
Researchers at the Massachusetts General Hospital and University of North Carolina (UNC) Kidney Center recently published in the journal Arthritis Research & Therapy a review on important aspects concerning the design of clinical trials for lupus nephritis. The study is entitled “Comparison and…
The Lupus Foundation of America is involved in an initiative named “Ask the Experts” based on a series of educational presentations focusing on several topics related to lupus. This initiative is a free service that allows participants to learn about the disease and ask questions to world’s leading lupus…
A recently published study led by Australian researchers from Monash University in Victoria has shown an association between Vitamin D levels and Lupus (SLE) disease activity. The study entitled, “Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort,” was published…
May is Lupus Awareness Month and the Lupus Research Institute (LRI), the S.L.E. Lupus Foundation and the LRI National Patient Coalition are committed to celebrating it through a series of events focused on the need for early disease diagnosis and novel research to improve the quality of life of…
The S.L.E. Lupus Foundation is advocating for wider access to medication for patients who suffer from systemic lupus erythematosus (SLE) by signing two Memorandums of Support for Legislative Acts. The non-profit organization, which works as part of the Lupus Agencies of New York State, believes that the memorandums can help…
Researchers at the Yale Cancer Center and the Veterans Affairs Greater Los Angeles Healthcare System, recently presented a new method to re-engineer lupus autoantibodies and transform them into potential cancer killers during the American Association for Cancer Research Annual Meeting 2015, Philadelphia. Systemic lupus erythematosus (SLE) is a…
The Lupus Foundation of America is hosting another edition of its Walk to End Lupus Now, an annual event that takes place across the country to support the fight against lupus, which is scheduled for Saturday, May 2. Last year the walk was the largest LFA-sponsored walk in the nation, gathering…